Alpha 2.0
Login Register
» Authors » Huaxin Shi

Huaxin Shi

Explore the profile of Huaxin Shi including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 7
Citations 118
Followers 0
Related Specialties
Rehabilitation Medicine
General Medicine
Top 10 Co-Authors
Hao Li
Jiaheng Shi
Cheng Lu
Wensheng Qi
Yongjun Bian
Luqi Huang
Li Zhang
Qing Miao
Guoju Dong
Luxing Leng
Published In
J Tradit Chin Med
Phytomedicine
Front Med (Lausanne)
Arch Biochem Biophys
J Ethnopharmacol
Affiliations
Soon will be listed here.
Recent Articles
1.
Human papillomavirus 16 E6/E7 contributes to immune escape and progression of cervical cancer by regulating miR-142-5p/PD-L1 axis
Ling J, Sun Q, Tian Q, Shi H, Yang H, Ren J
Arch Biochem Biophys . 2022 Oct; 731:109449. PMID: 36288761
Persistent infection of human papillomavirus (HPV) and immune escape are the main causes of cervical cancer. E6/E7 encoded by HPV16 may be closely related to carcinogenesis. HPV infection may upregulate...
2.
Chinese Medicine Formula Huashibaidu Granule Early Treatment for Mild COVID-19 Patients: An Unblinded, Cluster-Randomized Clinical Trial
Zhao C, Li L, Yang W, Lv W, Guo J, Dong Y, et al.
Front Med (Lausanne) . 2021 Oct; 8:696976. PMID: 34604251
Previous research suggested that Chinese Medicine (CM) Formula Huashibaidu granule might shorten the disease course in coronavirus disease 2019 (COVID-19) patients. This research aimed to investigate the early treatment effect...
3.
Combination of Hua Shi Bai Du granule (Q-14) and standard care in the treatment of patients with coronavirus disease 2019 (COVID-19): A single-center, open-label, randomized controlled trial
Liu J, Yang W, Liu Y, Lu C, Ruan L, Zhao C, et al.
Phytomedicine . 2021 Aug; 91:153671. PMID: 34425471
Objective: To evaluate the efficacy and safety of Hua Shi Bai Du Granule (Q-14) plus standard care compared with standard care alone in adults with coronavirus disease (COVID-19). Study Design:...
4.
Efficacy and safety assessment of severe COVID-19 patients with Chinese medicine: A retrospective case series study at early stage of the COVID-19 epidemic in Wuhan, China
Wang Y, Lu C, Li H, Qi W, Ruan L, Bian Y, et al.
J Ethnopharmacol . 2021 Feb; 277:113888. PMID: 33529638
Ethnopharmacological Relevance: The coronavirus disease 2019 (COVID-19) has formed a global pandemic since late 2019. Benefitting from the application experience of Chinese Medicine (CM) for influenza and SARS, CM has...
5.
Efficacy and safety of Chinese herbal medicine versus Lopinavir-Ritonavir in adult patients with coronavirus disease 2019: A non-randomized controlled trial
Shi N, Guo L, Liu B, Bian Y, Chen R, Chen S, et al.
Phytomedicine . 2020 Dec; 81:153367. PMID: 33260064
Background: Treatments for coronavirus disease 2019 (COVID-19) are limited by suboptimal efficacy. Methods: From January 30, 2020 to March 23, 2020, we conducted a non-randomised controlled trial, in which all...
6.
Effectiveness and safety of auricular acupoint bloodletting in treatment of insomnia: an assessor-blinded pilot randomized controlled trial
Ni J, Wang F, Wang B, Zhou H, Zhang N, Shi H, et al.
J Tradit Chin Med . 2020 Mar; 38(5):763-768. PMID: 32185994
Objective: To evaluate the effectiveness and safety of auricular acupoint bloodletting in treatment of insomnia METHODS: Participants (n = 60) with insomnia were randomized into two groups to receive treatment...
7.
Influence of clinical pathways used the hospitals of Traditional Chinese Medicine on patients hospitalized with stroke: a systematic review and Meta-analysis
Wang B, Chen D, Zhou H, Shi H, Xie Q
J Tradit Chin Med . 2018 Jul; 37(2):159-64. PMID: 29960286
Objective: To evaluate the influence of clinical pathways in the hospitals using the Traditional Chinese Medicine in treatment of stroke in terms of postoperative complications, length of stay (LOS), costs...